Patents by Inventor Heidi Lyng

Heidi Lyng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9809859
    Abstract: The present invention relates to biomarkers for chemoradioresistant subtypes of cervical cancer. In particular the present invention relates to a method for predicting a predisposition to a chemoradioresistant cervical cancer in a subject, a method for diagnosing a chemoradioresistant cervical cancer in a subject, a method for predicting the likelihood of recurrence of cervical cancer in a cervical cancer patient under treatment, and a method for predicting the prognosis for a patient with a chemoradioresistant cervical cancer.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: November 7, 2017
    Assignee: OSLO UNIVERSITETSSYKEHUS HF
    Inventors: Heidi Lyng, Malin Lando
  • Patent number: 9506117
    Abstract: The present invention relates to methods and biomarkers for detection of cervical cancer in biological samples, and in particular to markers associated with hypoxia related to the cervical cancer.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: November 29, 2016
    Assignee: Oslo universitetssykehus HF
    Inventors: Heidi Lyng, Cathinka Halle Julin
  • Publication number: 20160046997
    Abstract: The present invention relates to biomarkers for chemoradioresistant subtypes of cervical cancer. In particular the present invention relates to a method for predicting a predisposition to a chemoradioresistant cervical cancer in a subject, a method for diagnosing a chemoradioresistant cervical cancer in a subject, a method for predicting the likelihood of recurrence of cervical cancer in a cervical cancer patient under treatment, and a method for predicting the prognosis for a patient with a chemoradioresistant cervical cancer.
    Type: Application
    Filed: October 17, 2013
    Publication date: February 18, 2016
    Inventors: Heidi Lyng, Malin Lando
  • Publication number: 20150197818
    Abstract: The present invention relates to biomarkers for chemoradioresistant subtypes of cervical cancer. In particular the present invention relates to a method for predicting a predisposition to a chemoradioresistant cervical cancer in a subject, a method for diagnosing a chemoradioresistant cervical cancer in a subject, a method for predicting the likelihood of recurrence of cervical cancer in a cervical cancer patient under treatment, and a method for predicting the prognosis for a patient with a chemoradioresistant cervical cancer.
    Type: Application
    Filed: March 20, 2015
    Publication date: July 16, 2015
    Inventors: Heidi Lyng, Malin Lando
  • Publication number: 20150018242
    Abstract: The present invention relates to methods and biomarkers for detection of cervical cancer in biological samples, and in particular to markers associated with hypoxia related to the cervical cancer.
    Type: Application
    Filed: February 20, 2013
    Publication date: January 15, 2015
    Applicant: Mitsubishi Gas Chemical Company, Inc.
    Inventors: Heidi Lyng, Cathinka Halle Julin
  • Publication number: 20110224088
    Abstract: The present invention relates to biomarkers for chemoradioresistant subtypes of cervical cancer. In particular the present invention relates to a method for predicting a predisposition to a chemoradioresistant cervical cancer in a subject, a method for diagnosing a chemoradioresistant cervical cancer in a subject, a method for predicting the likelihood of recurrence of cervical cancer in a cervical cancer patient under treatment, and a method for predicting the prognosis for a patient with a chemoradioresistant cervical cancer.
    Type: Application
    Filed: March 11, 2011
    Publication date: September 15, 2011
    Inventors: Heidi Lyng, Malin Lando